Monday, 28 September 2026 Every NSE & BSE announcement, by company

ALFA Filings Every announcement, straight from the exchange

Accretion Pharmaceuticals Ltd

NSE: ACCPL · Pharmaceuticals & Biotechnology · 3 announcements

Share price: ₹203.30
Market cap: ₹226.0 Cr
Revenue (annual): ₹89.63 Cr
Net profit (annual): ₹9.67 Cr
P/E (TTM): 23.4×Sector 50.4×
Promoter holding: 73.52%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 1 Earnings Call 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

8 May 2026 16:07 IST NSE

Financial Results

Accretion Pharmaceuticals H2 FY26 Results: Net Profit ₹4.9 Cr, Up 14.0% YoY

Accretion Pharmaceuticals Ltd reported revenue from operations of ₹45.9 Cr (+18.3% YoY) and net profit of ₹4.9 Cr (+14.0% YoY) for H2 FY26.

Key figure: Net profit ₹4.9 Cr · +14.0% YoY

Open full results → Read the filing ↗